190 related articles for article (PubMed ID: 30397150)
1. Human-like hyperplastic prostate with low ZIP1 induced solely by Zn deficiency in rats.
Fong LY; Jing R; Smalley KJ; Wang ZX; Taccioli C; Fan S; Chen H; Alder H; Huebner K; Farber JL; Fiehn O; Croce CM
Proc Natl Acad Sci U S A; 2018 Nov; 115(47):E11091-E11100. PubMed ID: 30397150
[TBL] [Abstract][Full Text] [Related]
2. Human prostate cancer ZIP1/zinc/citrate genetic/metabolic relationship in the TRAMP prostate cancer animal model.
Costello LC; Franklin RB; Zou J; Feng P; Bok R; Swanson MG; Kurhanewicz J
Cancer Biol Ther; 2011 Dec; 12(12):1078-84. PubMed ID: 22156800
[TBL] [Abstract][Full Text] [Related]
3. hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer.
Franklin RB; Feng P; Milon B; Desouki MM; Singh KK; Kajdacsy-Balla A; Bagasra O; Costello LC
Mol Cancer; 2005 Sep; 4():32. PubMed ID: 16153295
[TBL] [Abstract][Full Text] [Related]
4. hZIP1 zinc transporter down-regulation in prostate cancer involves the overexpression of ras responsive element binding protein-1 (RREB-1).
Zou J; Milon BC; Desouki MM; Costello LC; Franklin RB
Prostate; 2011 Oct; 71(14):1518-24. PubMed ID: 21360563
[TBL] [Abstract][Full Text] [Related]
5. hZip2 and hZip3 zinc transporters are down regulated in human prostate adenocarcinomatous glands.
Desouki MM; Geradts J; Milon B; Franklin RB; Costello LC
Mol Cancer; 2007 Jun; 6():37. PubMed ID: 17550612
[TBL] [Abstract][Full Text] [Related]
6. The miR-183 family cluster alters zinc homeostasis in benign prostate cells, organoids and prostate cancer xenografts.
Dambal S; Baumann B; McCray T; Williams L; Richards Z; Deaton R; Prins GS; Nonn L
Sci Rep; 2017 Aug; 7(1):7704. PubMed ID: 28794468
[TBL] [Abstract][Full Text] [Related]
7. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions.
Hagman Z; Larne O; Edsjö A; Bjartell A; Ehrnström RA; Ulmert D; Lilja H; Ceder Y
Int J Cancer; 2010 Dec; 127(12):2768-76. PubMed ID: 21351256
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of metallothioneins (MTs) 1, 2, and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues.
Wei H; Desouki MM; Lin S; Xiao D; Franklin RB; Feng P
Mol Cancer; 2008 Jan; 7():7. PubMed ID: 18208603
[TBL] [Abstract][Full Text] [Related]
9. Integration of metabolomics, transcriptomics, and microRNA expression profiling reveals a miR-143-HK2-glucose network underlying zinc-deficiency-associated esophageal neoplasia.
Fong LY; Jing R; Smalley KJ; Taccioli C; Fahrmann J; Barupal DK; Alder H; Farber JL; Fiehn O; Croce CM
Oncotarget; 2017 Oct; 8(47):81910-81925. PubMed ID: 29137232
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
[TBL] [Abstract][Full Text] [Related]
11. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots.
Costello LC; Franklin RB
Mol Cancer; 2006 May; 5():17. PubMed ID: 16700911
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues.
Singh KK; Desouki MM; Franklin RB; Costello LC
Mol Cancer; 2006 Apr; 5():14. PubMed ID: 16595004
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of TRPM-2, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the Noble rat.
Ouyang XS; Wang X; Lee DT; Tsao SW; Wong YC
Carcinogenesis; 2001 Jun; 22(6):965-73. PubMed ID: 11375906
[TBL] [Abstract][Full Text] [Related]
14. Tissue-specific alterations in zinc transporter expression in intestine and liver reflect a threshold for homeostatic compensation during dietary zinc deficiency in weanling rats.
Jou MY; Hall AG; Philipps AF; Kelleher SL; Lönnerdal B
J Nutr; 2009 May; 139(5):835-41. PubMed ID: 19297427
[TBL] [Abstract][Full Text] [Related]
15. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis.
Song H; Zhang B; Watson MA; Humphrey PA; Lim H; Milbrandt J
Oncogene; 2009 Sep; 28(37):3307-19. PubMed ID: 19597465
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA dysregulation and esophageal cancer development depend on the extent of zinc dietary deficiency.
Fong LY; Taccioli C; Jing R; Smalley KJ; Alder H; Jiang Y; Fadda P; Farber JL; Croce CM
Oncotarget; 2016 Mar; 7(10):10723-38. PubMed ID: 26918602
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of drs mRNA in human prostate carcinomas.
Kim CJ; Shimakage M; Kushima R; Mukaisho K; Shinka T; Okada Y; Inoue H
Hum Pathol; 2003 Jul; 34(7):654-7. PubMed ID: 12874760
[TBL] [Abstract][Full Text] [Related]
18. N‑Myc induces the tumor progression of prostate cancer by regulating FSCN1.
He G; Li M; Fang L; Xu L; Huang X; Zheng L; Yang L; Luo W; Cai Y; Ma W; Liang C; Yin Y
Oncol Rep; 2020 Nov; 44(5):2265-2274. PubMed ID: 33000273
[TBL] [Abstract][Full Text] [Related]
19. HMGA2 expression in a canine model of prostate cancer.
Winkler S; Murua Escobar H; Meyer B; Simon D; Eberle N; Baumgartner W; Loeschke S; Nolte I; Bullerdiek J
Cancer Genet Cytogenet; 2007 Sep; 177(2):98-102. PubMed ID: 17854662
[TBL] [Abstract][Full Text] [Related]
20. A regulatory circuit HP1γ/miR-451a/c-Myc promotes prostate cancer progression.
Chang C; Liu J; He W; Qu M; Huang X; Deng Y; Shen L; Zhao X; Guo H; Jiang J; Fu XY; Huang R; Zhang D; Yan J
Oncogene; 2018 Jan; 37(4):415-426. PubMed ID: 28967902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
